India's Largest Database on New Projects
Nestlé Health Science acquires gastro diagnostics firm
26 May 2011: The new Health Science division Nestle has acquired a US gastroenterology and oncology diagnostic specialist, Prometheus Laboratories Inc., for an undisclosed sum.
Prometheus focuses on conditions such
as inflammatory bowel diseases, including Crohn's disease and ulcerative colitis
and has, “in-licensed specialty pharmaceuticals.”
Product areas will include: Nutren Fiber, Nutrisource Fiber, Fibersource,
Peptamen (Complete Elemental Nutrition) – for GI-compromised patients:
Prometheus's leading edge diagnostics and highly experienced medical sales representatives together constitute a robust platform for Nestlé Health Science to accelerate its current and future healthcare business. It will enable new personalised healthcare solutions based on diagnostics, pharma and nutrition.
Source: Nutraingrdients